Other pathways implicated in psoriasis, such as CCL20-CCR6, the IL-36/IL-1 pathway, the IFN pathway, and others involving cytokines like IL-22 and IL-6, are under investigation as potential targets for new drug development. The gene discussed is IFNA1; the disease is psoriasis.